TY - JOUR AU - Lee, Candice AU - Guel, David A. AU - Weksler, Benny PY - 2019 TI - Is there a role for upfront surgery in patients with N2 disease and good prognostic features? JF - Journal of Thoracic Disease; Vol 11, Supplement 9 (May 28, 2019): Journal of Thoracic Disease Y2 - 2019 KW - N2 - Patients with clinical stage IIIA-N2 non-small cell lung cancer (NSCLC) often pose a challenge to surgeons. The wide variability in patient management and outcomes is attributed in part to variability in tumor histology, size, location, and extent of N2 disease. This has spurred interest in identifying the optimal treatment of this heterogeneous group and whether all patients should be treated uniformly. The landmark study by Rosell et al . (1) demonstrated the inadequacy of surgery alone in the treatment of patients with N2 disease. The use of surgery alone in the treatment of patients with N2 has been put to rest. UR - https://jtd.amegroups.org/article/view/28060